EUDAMED · 28 NOVEMBER 2026 — Existing-device registration deadline. See the EUDAMED Exposure Map →

Bring the decision, deadline, or exposure. We will help clarify the next move.

Share the regulatory, clinical, quality, portfolio, renewal, submission, or Notified Body issue affecting the organization.

Each inquiry is reviewed directly to determine fit and the most useful next step, with a response typically provided within 1–2 business days.

Email
info@shotunemedconsulting.com
Location
San Francisco, California
LinkedIn
Connect on LinkedIn

Start here

Schedule a Confidential Strategy Discussion.

Share the renewal or submission timeline, known concerns, previous findings, and the documents currently available. For another issue, describe the situation and the decision that needs clarification.

This field is for validation purposes and should be left unchanged.
Consent(Required)

By submitting this form, you consent to SHOTUNE processing and storing the information you provide so the team can respond to your inquiry. You may withdraw consent at any time. Review the Privacy Policy.

A direct review of the situation, the available documentation, and the appropriate next step.

Step 1

Describe the situation

Provide the renewal or submission timeline, known concerns, previous findings, and the documentation currently available.

Step 2

The request is reviewed

The inquiry is reviewed across the relevant regulatory, clinical, quality, post-market, risk, and technical-documentation signals to determine the appropriate scope.

Step 3

Receive a direct response

You will receive a reply within 1–2 business days with the appropriate next step.

Back To Top